24 Mar SAHPRA Recalls Affected batches of Citro-Soda Regular Following Safety Concerns
Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) today briefed members of the media on the recall of specific batches of Citro-Soda Regular products, reaffirming its commitment to protecting public health and ensuring the safety, quality, and efficacy of all health products available in South Africa.
The recall follows the identification of a potential risk of foreign material contamination during an inspection conducted at the Adcock Ingram Clayville, Johannesburg, manufacturing facility. As a precautionary measure, SAHPRA took regulatory action to recall the affected batches of these products.
The recall is limited to specific batches of the following Citro-Soda Regular products:
- Citro-Soda Regular 60 g
- Citro-Soda Regular 120 g
- Citro-Soda Regular 4 g x 30 Sachets
For affected batches of Citro-Soda Regular products, please click here.
During the briefing, SAHPRA emphasised that this action forms part of its routine regulatory oversight and risk-based approach to safeguarding public health. SAHPRA also reassured the public that it continues to actively monitor the situation and engage with the manufacturer to ensure full compliance with regulatory requirements.
Retail pharmacies, wholesalers, and distribution centres have been instructed to cease the sale of affected batches and to return all stock to their respective suppliers. Consumers who have purchased the affected products are advised to return them to the nearest health facility, pharmacy, or store.
Members of the public who may have consumed the affected products and are experiencing any adverse side effects are urged to visit their nearest health facility and report such incidents to SAHPRA.
“The safety and well-being of the public remain our highest priority. SAHPRA will continue to act decisively and transparently to ensure that all health products on the market meet the required standards, of quality, safety and efficacy,” said the Chief Executive Officer of SAHPRA, Dr Boitumelo Semete-Makokotlela.
SAHPRA will continue to monitor this recall to ensure that all affected batches are destroyed. Furthermore, SAHPRA will monitor compliance at the affected facility until they have satisfactorily implemented corrective actions and preventative actions prescribed to them.
